Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy

par Mohabati D, van Rijssen TJ, van Dijk EHC, Luyten GPM, Missotten TO, Hoyng CB, Yzer S, Boon CJF
Publié 2018

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy

par Shimizu K, Hashimoto Y, Azuma K, Nomura Y, Obata R, Takahashi H, Yanagi Y
Publié 2017

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

par Asahi MG, Chon AT, Gallemore E, Gallemore RP
Publié 2017

Central Serous Chorioretinopathy: Pathogenesis and Management

par Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, Bartollino S, Costagliola C
Publié 2019

Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model

par Abdelhakeem E, El-nabarawi M, Shamma R
Publié 2021

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

par Breukink MB, Dingemans AJM, den Hollander AI, Keunen JEE, MacLaren RE, Fauser S, Querques G, Hoyng CB, Downes SM, Boon CJF
Publié 2016

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

par Mohabati D, van Dijk EHC, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, Dijkman G, Hoyng CB, Fauser S, Yzer S, Boon CJF
Publié 2018

Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density

par Fujimura S, Ueda K, Nomura Y, Yanagi Y
Publié 2016